| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 5 | |
| #2 | EPO (European Patent Office) | 4 | |
| #3 | United States | 3 | |
| #4 | China | 2 | |
| #5 | Canada | 1 |
| # | Industry | |
|---|---|---|
| #1 | Organic fine chemistry | |
| #2 | Pharmaceuticals | |
| #3 | Biotechnology | |
| #4 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Heterocyclic compounds | |
| #2 | Therapeutic chemical compounds | |
| #3 | Medical preparations | |
| #4 | Analysing materials | |
| #5 | Peptides | |
| #6 | Microorganisms |
| # | Name | Total Patents |
|---|---|---|
| #1 | Carrasco Esther | 8 |
| #2 | Vega Miguel | 8 |
| #3 | Campos Pedro | 8 |
| #4 | Carrasco Romero Esther | 7 |
| #5 | Campos Muelas Pedro | 7 |
| #6 | Messeguer Ángel | 7 |
| #7 | Gómez Patricia | 7 |
| #8 | Messeguer Peypoch Ángel | 5 |
| #9 | Burguete Pérez Asunción | 5 |
| #10 | Gómez Gutiérrez Patricia | 5 |
| Publication | Filing date | Title |
|---|---|---|
| WO2020099603A1 | Pyridin-sulfonamide compounds for the treatment of conditions related to interleukin 1 beta | |
| EP3763711A1 | Tetrahydroisoquinoline compounds | |
| CN112262137A | Tetrahydroisoquinoline compounds | |
| CN106661050A | P38 and jnk mapk inhibitors for the treatment and prophylaxis of degenerative diseases of the nervous system | |
| EP2931883A1 | P38 mapk inhibitors for the treatment of inflammatory diseases |